000 01582 a2200469 4500
005 20250517061719.0
264 0 _c20160503
008 201605s 0 0 eng d
022 _a1872-7980
024 7 _a10.1016/j.canlet.2015.10.025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJu, Rui
245 0 0 _aCarboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition.
_h[electronic resource]
260 _bCancer letters
_cJan 2016
300 _a232-41 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aDeoxyglucose
_xpharmacology
650 0 4 _aDrug Synergism
650 0 4 _aGlucose
_xmetabolism
650 0 4 _aGlycolysis
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aOxidative Phosphorylation
_xdrug effects
650 0 4 _aOxygen Consumption
_xdrug effects
650 0 4 _aTriazoles
_xpharmacology
700 1 _aGuo, Lei
700 1 _aLi, Juan
700 1 _aZhu, Lei
700 1 _aYu, Xiaoli
700 1 _aChen, Chen
700 1 _aChen, Wei
700 1 _aYe, Caiying
700 1 _aZhang, Dechang
773 0 _tCancer letters
_gvol. 370
_gno. 2
_gp. 232-41
856 4 0 _uhttps://doi.org/10.1016/j.canlet.2015.10.025
_zAvailable from publisher's website
999 _c25407491
_d25407491